Keyword: Olivier Brandicourt
Sanofi says its GLP-1 drug SAR425899 is undertaking new tests to try to get around dosing issues that is causing GI problems.
Longtime Catalent CFO joins Allergan, Arcturus board and ousted CEO exchange fire, Lilly diabetes executive jumps to MannKind.
Sanofi Genzyme's CEO Meeker will step down amid key rollouts, Allergan's chief strategy officer Patel became CEO at startup Relay, and more.
Sanofi had a bit of a year to forget when it came to buying up biotechs and expanding its pipeline—it failed to beat out Pfizer in its winning $14 billion bid for cancer biotech Medivation, losing out on some increasingly hot cancer candidates and blockbuster prostate cancer med Xtandi.